Manatt Represents Oxford Finance in $500M Debt Financing Agreement

Manatt Financial Services Partner and Associate represented Oxford Finance LLC in the closing of a landmark $500 million debt financing agreement with Vera Therapeutics, Inc., a clinical-stage biotechnology company focused on developing treatments for serious immunological diseases. Vera Therapeutics is an existing borrower of Oxford and in their expanded partnership, $75 million is funded at close, with up to $425 million of additional availability.

Vera is advancing atacicept for the treatment of Berger’s disease, and in connection with this debt facility, announced positive topline Phase 3 data that continues to support its potential as a disease-modifying therapy.

Learn more about the deal .